Quantcast
Home / DC News / Generic drug preemption ruling a blow to plaintiffs

Generic drug preemption ruling a blow to plaintiffs

WASHINGTON – The U.S. Supreme Court’s decision barring state-law design-defect claims against generic drug makers that mirror failure-to-warn actions served a major setback to plaintiffs seeking damages for drug injuries.


Lawyers USA has ceased publication. If you have purchased a research pass or still have additional time on your current Digital Subscription, you may access locked stories by logging in:







Scroll To Top